Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The

    Published: January 1, 2006 | Price: $3,500.00 – $7,000.00

    The U.S. long-term care industry experienced strong growth from 1999 through 2004 and this growth is expected to continue through the end of the decade. Indeed, the aging of the U.S. population will push unprecedented demand for all forms of long-term care, but ongoing cost containment issues continue to pressure both private and public managed care organizations and make competition in this dynamic environment challenging. This comprehensive study from Kalorama Information details four segments of the long-term care industry, including:...
    Outsourcing in Drug Discovery, 2nd Edition

    Published: January 1, 2006 | Price: $2,995.00 – $5,990.00

    In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study involved completely re-examining the market from the ground up. This new report is designed to make readers aware of the enormous changes that are taking place in the drug discovery outsourcing market, and the forces that are shaping the sector. It presents viewpoints from both customers...
    Advanced Drug Delivery – Technologies, Applications, and Markets, 2nd Ed.

    Published: November 15, 2005 | Price: $2,500.00 – $7,000.00

    This completely updated 2nd edition to Kalorama’s popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical products in the United States. Taking a strategic view of the various therapeutic areas on which drug delivery is anticipated to have its greatest impact, the report considers the options that the current technologies present, the progress that is being made in these fields, and the reception these new products...
    Worldwide Market for Pediatric Drugs, 2nd Edition, The

    Published: November 1, 2005 | Price: $3,500.00 – $7,000.00

    Although, the next 15-20 years will shift a majority of the population into the elderly population group, children will continue to remain the bulk of the dependent population worldwide with 9 in every 10 people falling into a pediatric age range in the less developed regions of Africa, Asia and Latin America. Therefore, the treatment of conditions and diseases affecting pediatrics and the healthy growth of children are vital to providing a solid foundation for healthy adults in the future....
    Market for Generic Biologics – Issues, Trends, and Market Potential, 2nd edition, The

    Published: November 1, 2005 | Price: $2,500.00 – $5,000.00

    Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion (and growing at over 10% per year) to generic competition, if—and it’s a big if—the regulatory hurdles for these generics can be overcome. Biogeneric is a new term combining biologic...
    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    Published: November 1, 2005 | Price: $4,995.00 – $9,990.00

    There has not been a year in the last decade in which the IVD market in China has failed to grow. With a gross domestic product of over $1.4 trillion, China surpassed Italy last year to become the world’s sixth largest economy, according to the International Monetary Fund. This country of 1.3 billion people is now America’s sixth largest export market, and China’s economy, which has been growing at an average rate of 8% over the last 20 years, grew...
    World Market for Respiratory Equipment, The

    Published: November 1, 2005 | Price: $3,500.00 – $7,000.00

    Respiratory diseases are among the most common ailments across the world. Asthma and chronic obstructive pulmonary disease (COPD) are the major causes of mortality rates among children and elderly. Currently, about 300 million people suffer from asthma—the number only expected to rise over next few years—and about 14.2 million people suffer from COPD. Given these numbers, it’s no wonder that the market for respiratory products is buoyant. This report analyzes the worldwide market for respiratory disposables and reusables, including the...
    Worldwide Market for Cancer Diagnostics, The

    Published: October 1, 2005 | Price: $3,500.00 – $7,000.00

    Cancer, with its high prevalence and mortality rate, continues to rank among the world's deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are making continued progress in understanding the disease. Further, cancer drug research is moving from traditional cytotoxic chemotherapies toward higher specificity immunological and biological approaches that...
    U.S. Market for Clinical Information Systems – An Analysis of the Growing Use of Information Technology for Hospital-Based Patient Care, The

    Published: October 1, 2005 | Price: $895.00 – $5,990.00

    Information technology (IT) has the potential to improve the quality, safety and efficiency of clinical care. IT is not new to the hospital setting. Computers and software have been used for many years to improve the paper-based administrative functions of hospital support staff, such as scheduling and billing. But the use of IT in the clinical setting to optimize, streamline and simplify patient records, testing, imaging and operating room procedures has lagged behind its medical administrative applications. The evolution of...
    Implant-Based Dental Reconstruction – The Worldwide Implant and Bone Graft Market

    Published: September 1, 2005 | Price: $995.00 – $7,000.00

    In the industrial world, over 240 million people lack one or more teeth. It is estimated that 40% of the western population is missing one tooth or more. In the United States, approximately 10% is the population is totally edentulous, and every year about two million Americans loose a tooth due to sporting accidents. Although the success of modern dentistry in the United States has vastly decreased the edentulous rate in each succeeding generation, it is estimated there are about...
    The U.S. Market For Cardiovascular Devices

    Published: September 1, 2005 | Price: $3,500.00 – $7,000.00

    This report considers the markets for therapeutic cardiovascular devices, such as prosthetic valves, pacemakers, stents, support devices, ICDs, VADs, and TAHs, in the United States as broken down into four major segments: cardiomyopathy/congestive heart failure arrhythmias arteriosclerosis (coronary artery disease), and valvular heart disease While there are other cardiovascular conditions that remain significant in the American population, e.g., stroke and myocardial infarction, these four conditions present the core conditions that lead to more serious cardiovascular accidents and death and present...
    Wound Care Markets, 2nd Edition, Vol III – Surgical and Trauma Wounds

    Published: September 1, 2005 | Price: $2,995.00 – $5,990.00

    Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, but it is by no means the easiest to compete in. There are millions of surgical procedures performed annually worldwide; in the United States alone, there are over 100,000 surgeries performed daily. Enjoying market success depends on developing a formidable strategy that involves matching internal capabilities with external opportunities. Providers who compete well in this area must offer products that achieve...
    The World Market for Neurotherapeutic Drugs

    Published: September 1, 2005 | Price: $3,500.00 – $7,000.00

    Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimer’s Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
    Glycosylated Protein Therapeutics – A Market Briefing

    Published: September 1, 2005 | Price: $795.00 – $1,590.00

    One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The glycosylated therapeutics business is among the faster growing segments in the drug industry, but the development of novel glycosylated therapies is only in the early...
    Wound Care Markets, 2nd Edition, Vol II – Burns

    Published: August 1, 2005 | Price: $2,995.00 – $5,990.00

    Approximately 27 million burn cases requiring professional treatment occur worldwide each year, and of these 7 million will require hospitalization and more than a million will die as a direct result of their burns. Burn injuries are a particularly difficult and painful area of medicine requiring multi-pronged approach to address infection, pain, and a host of long-term complications. Continued advances in biotechnology have driven the burn portion of the wound care industry, estimated at over $1.5 billion globally. New wound...
    The Market for Clinical Nutritional Products

    Published: August 1, 2005 | Price: $2,500.00 – $5,000.00

    This market briefing concentrates on the U.S. market for medical nutritional support—in particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and techniques have evolved from steady improvements, including the use of antibiotic materials, biosensors, wireless communications, and more efficient pumps and controllers. These new developments have...
    Complex Regional Pain Syndrome (CRPS) – A Market Briefing

    Published: August 1, 2005 | Price: $795.00 – $1,990.00

    Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection. On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as...
    Wound Care Markets, 2nd Edition, Vol I – Skin Ulcers

    Published: July 1, 2005 | Price: $2,995.00 – $5,990.00

    The aging of the population and continued advances in biotechnology drive the skin ulcer portion of the wound care industry, estimated at $3.3 billion globally. A lack of effective treatment options has heretofore added to the increased costs of skin ulcer treatment and has contributed to the growing frustration in the industry. New product manufacturers can capitalize on these concerns by offering products designed to improve healing rates and prevent wound formation within a cost-conscious framework. Besides the always-improving synthetic...
    The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications

    Published: July 1, 2005 | Price: $3,000.00 – $6,000.00

    This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace. In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of...
    U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.

    Published: June 1, 2005 | Price: $3,500.00 – $7,000.00

    Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. This completely updated 2nd edition of Kalorama’s popular 2003 study thoroughly...
    The World Market for Anti-Infectives, Volume III – Antivirals

    Published: June 1, 2005 | Price: $2,500.00 – $5,000.00

    This volume of Kalorama Information’s World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides an An overview Description of products on the market Description of products in development Market estimates and forecasts through 2009 Market segmentation by infection type Market segmentation by geographic region Market share of leading...
    The U.S. Market for Home Care Products, 4th Edition

    Published: June 1, 2005 | Price: $3,500.00 – $7,000.00

    The U.S. market for home care products and equipment continues to post steady gains, primarily as a result of the aging population and increasing shifts of chronic care patients from hospitals to home. In 2004, an estimated 16 million people received home health care in the United States, and most of these individuals also used associated home care products. Through 2009, the numbers of home care patients will continue to grow as patient lifespans are extended with more sophisticated medical...
    Minimally Invasive Spinal Surgery – A Market Briefing

    Published: June 1, 2005 | Price: $995.00 – $1,990.00

    With the promise of improved outcomes and shorter recovery times and costs, endoscopic surgery has evolved into an accepted surgical discipline in most therapeutic areas. However, spine surgeons in particular have been slow to embrace this new technology over the past decade or so. Challenges specific to the spinal column have made the adoption of minimally invasive surgery difficult, but endoscope manufacturers have begun to take advantage of technological advances in endoscopic visualization and other arrears to optimize the minimal-access...
    Molecular Imaging Agents and Systems – A Market Briefing

    Published: June 1, 2005 | Price: $995.00 – $1,990.00

    Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis. Research groups around the world are joining the effort to use magnetic, nuclear, and optical imaging techniques to study the molecular interactions that underlie biological processes. This market briefing presents an overview of the market for molecular imaging agents and systems. The briefing provides an introduction to molecular imaging modalities and applications, and focuses on imaging agents...
    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    Published: June 1, 2005 | Price: $995.00 – $1,990.00

    In addition to being one of the most important tissues in the body, blood has emerged as a key vector in the transmission of the world's deadliest infectious diseases. With the rising demand for transfusions in a variety of conditions such as anemias, trauma, and high-blood-loss surgeries, supplies have been stretched and the dangers of disease transmission have added significant cost pressures to maintaining a safe supply. One possible solution to ease the crunch, particularly in acute amergency care settings...
    Hispanics and Healthcare: Understanding Demographics, Health Statistics, and Attitudes for More Effective Marketing

    Published: May 1, 2005 | Price: $1,995.00 – $3,990.00

    In the last decade the importance of reaching the Hispanic market has become increasingly apparent to marketing practitioners in all industries. Hispanics have not only increased in numbers to become the largest ethnic minority population in the United States, but also increased in purchasing power, representing an estimated $680 billion in 2004 and expected to grow at an average annual rate of 8%. For many industries, including pharmaceutical and healthcare, Hispanics constitute an unfamiliar segment of the market, but one...
    Markets in Human Reproductive Medicine

    Published: May 1, 2005 | Price: $3,500.00 – $7,000.00

    This study provides a comprehensive analysis of available and emerging reproductive products and technologies related to contraception and infertility treatments. The goal of this study is to provide a comprehensive range of information from detailed product analyses through industry trends, and to quantify and qualify the market for hormonal contraceptives, infertility pharmaceuticals, and for assisted reproductive technologies. The report forecasts the following markets through 2008: The world market oral contraceptives The world market hormonal contraceptive devices The world market infertility...
    The World Market for Anti-Infectives, Volume II – Antibacterials

    Published: May 1, 2005 | Price: $2,500.00 – $5,000.00

    For the past 60 years, antibiotic drugs have changed bacterial infections from the life-threatening scourges they once were into eminently treatable conditions. However, the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to traditional agents. As a result, pharmaceutical companies are taking a second look at the antibiotic market, after more than two decades of relative complacency. In addition to the scientific and technical challenges of new antibiotic development, there are significant...
    The Worldwide Market for Prescription Cardiovascular Drugs

    Published: May 1, 2005 | Price: $3,500.00 – $7,000.00

    The worldwide market for prescription cardiovascular drugs encompasses a wide variety of products that treat the many facets of cardiovascular disease. The field of cardiology is currently experiencing a busy and dynamic period. As a result, the range of therapeutic options available to physicians has expanded significantly in the past few years and the development pipeline promises even more weapons soon. The sheer size and diversity of the current market and the potential of new products make this therapeutic category...
    Informatics in Drug Discovery: The Evolving Information Technology Marketplace

    Published: May 1, 2005 | Price: $3,000.00 – $6,000.00

    Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced. In the rapidly changing field of informatics, it is difficult to decode the buzz-words, interpret the extravagant claims, separate true needs from blue-sky wishes. The concerns and strategies of only a year ago...